Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Pandion Therapeutics, Inc. (PAND)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-20 | Sep-30-20 | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 |
| | 10-K | 10-Q | 10-Q | S-1/A | 10-K | 10-Q | 10-Q | S-1/A |
| Net income | -11.2 | -11.9 | -11.9 | 0.0 | -5.6 | -6.9 | -6.7 | 0.0 |
| Depreciation and amortization [+] | 0.2 | 0.2 | 0.2 | | 0.1 | 0.1 | 0.1 | |
| Depreciation | 0.2 | 0.2 | 0.2 | | 0.1 | 0.1 | 0.1 | |
| Stock-based compensation | 1.1 | 1.3 | 0.2 | | 0.1 | 0.0 | 0.0 | |
| Change in working capital [+] | 1.4 | -2.8 | 1.2 | | 7.1 | 1.4 | -0.3 | |
| Accounts receivable | 1.2 | -0.8 | -0.3 | | -1.0 | | | |
| Other current assets | -0.1 | -0.2 | 0.1 | | -2.5 | 0.3 | 0.5 | |
| Accounts payable | -0.7 | -0.4 | 1.6 | | 0.0 | 0.2 | 0.1 | |
| Deferred revenues | -1.2 | -0.5 | -1.1 | | | | | |
| Other | 2.3 | -0.8 | 0.8 | | 10.5 | 0.9 | -0.9 | |
| Other operating activities | -2.6 | 3.5 | -3.8 | | 1.3 | 0.7 | -4.8 | |
| Cash from operations | -11.2 | -9.7 | -14.1 | | 2.9 | -4.7 | -11.6 | |
| |
| Capital expenditures | -0.8 | -0.8 | -1.2 | | -0.2 | 0.0 | -0.4 | |
| Purchases of property and equipment | -0.8 | -0.8 | -1.2 | | -0.2 | | -0.4 | |
| Cash from investing | -0.8 | -0.8 | -1.2 | | -0.2 | 0.0 | -0.4 | |
| |
| Issuance of common stock, net | | 146.9 | 6.0 | | | | | |
| Financing costs | | | | | -0.1 | | | |
| Other cash from financing | -0.5 | -9.8 | 99.6 | | 1.8 | | 18.0 | |
| Cash from financing | -0.5 | 137.1 | 105.6 | | 1.9 | 0.0 | 18.0 | |
| |
| Free cash flow | -12.0 | -10.5 | -15.3 | | 2.7 | -4.7 | -12.1 | |
| Per share (diluted) | ($0.88) | ($0.45) | ($13.01) | | $2.60 | ($4.59) | ($11.40) | |
| |
| Cash paid for interest | | 0.0 | 0.0 | | | | | |
|